TSX:BHC (Bausch Health Companies Inc.)

About BHC

Bausch Health Companies Inc. is a global company that develops manufactures and markets a range of pharmaceutical medical device and over-the-counter products primarily in the therapeutic areas of eye health gastroenterology and dermatology. We are delivering on our commitments as we build an innovative company dedicated to advancing global health. Our approximately 22000 employees are united around our mission of improving peoples lives with our health care products and we manufacture and market health care products directly or indirectly in approximately 100 countries. Five pillars or guiding principles represent the foundation on which we are realizing our mission as an organization: People Quality Health Care Outcomes Customer Focus Innovation and Efficiency.
  • Bausch Health Companies Inc. (TSX: BHC) Latest News

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc.: If You Believe Management, it’s a Screaming Buy

    Most Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) bears say investors can't trust the company's management. But what if they're wrong and…

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc.: the 3 Biggest Takeaways From its Latest Conference Call

    Vealeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) continues its damage-control efforts.

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc.: Why its Pricing Strategy Is Immoral and Unsustainable

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) uses backdoor tactics to overcharge for its products.

    Read more »

    The Motley Fool
    Investing

    Why Are Shares of Valeant Pharmaceuticals Intl Inc. Plunging This Time?

    Shares of Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) are once again in free fall. What's going on this time?

    Read more »

    The Motley Fool
    Investing

    The 3 Biggest Threats Facing Valeant Pharmaceuticals Intl Inc.

    Think the troubles for Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) are over? Think again.

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc. Has Lost $100 Billion in Value Since August. Is it Going to $0?

    With nearly no clarity into the company’s startling allegations, it’s tough to recommend that anyone should own Valeant Pharmaceuticals Intl…

    Read more »

    The Motley Fool
    Investing

    Why Bill Ackman Thinks Valeant Pharmaceuticals Intl Inc. Will Quadruple in 3 Years

    Bill Ackman thinks that Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) is wildly misunderstood. Is he right?

    Read more »

    The Motley Fool
    Investing

    Don’t Be Fooled by Valeant Pharmaceuticals Intl Inc.

    Value investors are starting to sniff around Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX). Here's why it could be the ultimate value…

    Read more »

    Investing

    Valeant Pharmaceuticals Intl Inc. Has No Friends

    Nobody likes Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX), and that could spell big trouble for the company.

    Read more »

    The Motley Fool
    Investing

    Should Investors Avoid Concordia Healthcare Corp.?

    Concordia Healthcare Corp. (TSX:CXR)(NASDAQ:CXRX) is being held back due to political pressure on a competitor, but does the recent acquisition…

    Read more »

    The Motley Fool
    Investing

    2 Ways That Valeant Pharmaceuticals Intl Inc. Shares Could Get Crushed

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) has some big problems on its hands.

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc. May Not Be an Enron, But Trouble Lies Ahead

    Now is not the time to own Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX).

    Read more »